New technology for creating radiolabeled peptides for imaging and treatment
Catch and Release Radiolabeled Peptides: a new technology for radiotracer development
['FUNDING_R21'] · STATE UNIVERSITY NEW YORK STONY BROOK · NIH-10885928
This study is working on a new way to make special tiny proteins that can help doctors see and treat cancer better, using smart technology to make the process easier and more effective for patients.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | STATE UNIVERSITY NEW YORK STONY BROOK (nih funded) |
| Locations | 1 site (STONY BROOK, UNITED STATES) |
| Trial ID | NIH-10885928 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel method for creating radiolabeled peptides, which are important for imaging and treatment in various medical fields, particularly oncology. The approach utilizes advanced automation and innovative chemistry to produce high-purity radiotracers that can be easily integrated into existing peptide synthesis processes. By streamlining the production of these peptides, the research aims to enhance their application in drug discovery and clinical settings, ultimately improving diagnostic and therapeutic options for patients. The project seeks to leverage existing technologies to create a robust platform for the synthesis and evaluation of these valuable compounds.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing evaluation or treatment for cancers or other conditions that could benefit from advanced imaging techniques.
Not a fit: Patients with conditions that do not require imaging or treatment involving radiolabeled peptides may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective imaging and treatment options for patients with various conditions, particularly cancers.
How similar studies have performed: Other research has shown promise in the use of radiolabeled peptides for imaging and treatment, indicating that this approach has the potential for significant advancements.
Where this research is happening
STONY BROOK, UNITED STATES
- STATE UNIVERSITY NEW YORK STONY BROOK — STONY BROOK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PARKER, MATTHEW — STATE UNIVERSITY NEW YORK STONY BROOK
- Study coordinator: PARKER, MATTHEW
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Bone Infection